Evidence map›Paper›PMID 14512476›Full record

Trial reportBMJ (Clinical research ed.)2003

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.

TREC Collaborative Group

Registry-linked trialAbstract readClinical TrialComparative StudyMulticenter Study
In one paragraph

Trial report in BMJ (Clinical research ed.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03554915 (Ketamine Versus Midazolam for Prehospital Agitation), which is not on this map. Cited by 50 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03554915 completednot on this mapstarted 2017, after this paper: background citation

Ketamine Versus Midazolam for Prehospital Agitation

TypeobservationalSponsorHennepin Healthcare Research InstituteRan2017 to 2018Enrolled314ConditionsAgitationArmsKetamine-based protocol, Midazolam-based protocol
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Droperidol for psychosis-induced aggression or agitation.The Cochrane database of systematic reviews · 2016
    Pooled it
  5. Haloperidol plus promethazine for psychosis-induced aggression.The Cochrane database of systematic reviews · 2016
    Pooled it
  6. Intermittent drug techniques for schizophrenia.The Cochrane database of systematic reviews · 2013
    Pooled it
  7. Benzodiazepines for schizophrenia.The Cochrane database of systematic reviews · 2012
    Pooled it
  8. Chlorpromazine for psychosis induced aggression or agitation.The Cochrane database of systematic reviews · 2010
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Clotiapine for acute psychotic illnesses.The Cochrane database of systematic reviews · 2004
    Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

TREC Collaborative Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare two widely used drug treatments for people with aggression or agitation due to mental illness.

designPragmatic, randomised clinical trial.

settingThree psychiatric emergency rooms in Rio de Janeiro, Brazil. SUBJECTS: 301 aggressive or agitated people.

interventionsOpen treatment with intramuscular midazolam or intramuscular haloperidol plus promethazine.

main outcome measuresPatients tranquil or sedated at 20 minutes. SECONDARY OUTCOMES: patients tranquil or asleep by 40, 60, and 120 minutes; restrained or given extra drugs within 2 hours; severe adverse events; another episode of agitation or aggression; needing extra visits from doctor during first 24 hours; overall antipsychotic load in first 24 hours; and not discharged by two weeks.

results151 patients were randomised to midazolam, and 150 to haloperidol-promethazine mix. Follow up for the primary outcome was available for 298 (99%): 134/151 (89%) of patients given midazolam were tranquil or asleep after 20 minutes compared with 101/150 (67%) of those given haloperidol plus promethazine (relative risk 1.32 (95% confidence interval 1.16 to 1.49)). By 40 minutes, midazolam still had a statistically and clinically significant 13% relative advantage (1.13 (1.01 to 1.26)). After 1 hour, about 90% of both groups were tranquil or asleep. One important adverse event occurred in each group: a patient given midazolam had transient respiratory depression, and one given haloperidol-promethazine had a grande mal seizure.

conclusionsBoth treatments were effective. Midazolam was more rapidly sedating than haloperidol-promethazine, reducing the time people are exposed to aggression. Adverse effects and resources to deal with them should be considered in the choice of the treatment.

Indexed as

AggressionAdultDrug Therapy, CombinationEmergency Service, HospitalEmergency Services, PsychiatricEmergency TreatmentFemaleHaloperidolHospitals, PsychiatricHumansInjections, IntramuscularMaleMental DisordersMidazolamPromethazinePsychomotor AgitationHaloperidolMidazolamPromethazineTranquilizing Agents

Identifiers

PMID14512476
PMCPMC200800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.